DUNCAN BARBARA GAYLE bought HALO
May 5, 2026 · Form 4 insider transaction
DUNCAN BARBARA GAYLE bought 6,040 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,040
Price
$0.00
Total value
N/A
InsiderDUNCAN BARBARA GAYLE
RoleDirector
SecurityOption to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateMay 5, 2026
Filing dateMay 7, 2026
Shares owned after6,040
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.